Astrazeneca
Nasdaq Stockholm · LEI PY6ZZQWO2IZFZC3IOL08· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Quick read
- Revenue grew 8.6% year over year.
- Revenue has grown two years in a row.
- Operating margin was 23.4% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- Operating margin
- 23.4%
- Net margin
- 17.4%
- ROE
- 21.0%
- Debt-to-equity
- 134.3%
- Equity ratio
- 42.7%